Skip to main content
Top
Published in: BMC Pediatrics 1/2022

Open Access 01-12-2022 | Septic Shock | Research

Time to appropriate antimicrobial therapy serves an independent prognostic indicator in children with nosocomial Klebsiella pneumoniae bloodstream infection

Authors: Jie Cheng, Qinyuan Li, Guangli Zhang, Huiting Xu, Yuanyuan Li, Xiaoyin Tian, Dapeng Chen, Zhengxiu Luo

Published in: BMC Pediatrics | Issue 1/2022

Login to get access

Abstract

We tend to investigate the connection between time to appropriate therapy (TTAT) and prognosis in pediatric patients with nosocomial Klebsiella pneumoniae (K. pneumoniae) bloodstream infection, and find the optimal cutoff point for the empirical administration of antimicrobials. This retrospective study was conducted in Children’s Hospital of Chongqing Medical University, and inpatients with nosocomial K. pneumoniae bloodstream infection were finally enrolled. We applied the Classification and Regression Tree (CART) analysis to find the TTAT cutoff point and the Logistic Regression analysis to evaluate prognostic indicators. The incidence of septic shock and mortality was 17.91% (12/67) and 13.43% (9/67), respectively. The CART-derived TTAT cutoff point was 10.7 h. The multivariate logistic regression analysis indicated delayed therapy (TTAT ≥ 10.7 h), pediatric risk of mortality (PRISM) III scores ≥ 10, time to positivity (TTP) ≤ 13 h, and requiring for invasive mechanical ventilation were independently associated with the incidence of septic shock (Odds ratio [OR] 9.87, 95% Confidence interval [CI] 1.46–66.59, P = 0.019; OR 9.69, 95% CI 1.15–81.39, P = 0.036; OR 8.28, 95% CI 1.37–50.10, P = 0.021; OR 6.52, 95% CI 1.08–39.51, P = 0.042; respectively) and in-hospital mortality (OR 22.19, 95% CI 1.25–393.94, P = 0.035; OR 40.06, 95% CI 2.32–691.35, P = 0.011; OR 22.60, 95% CI 1.78–287.27, P = 0.016; OR 12.21, 95% CI 1.06–140.67, P = 0.045; respectively).
Conclusions TTAT is an independent predictor of poor outcomes in children with nosocomial K. pneumoniae bloodstream infection. Initial appropriate antimicrobial therapy should be administrated timely and within 10.7 h from the onset of bloodstream infection is recommended.
Literature
9.
go back to reference Falcone M, Bassetti M, Tiseo G, Giordano C, Nencini E, Russo A, . . . Menichetti F. Time to appropriate antibiotic therapy is a predictor of outcome in patients with bloodstream infection caused by KPC-producing Klebsiella pneumoniae. Crit Care (London Engl). 2020;24(1):29. https://doi.org/10.1186/s13054-020-2742-9.CrossRef Falcone M, Bassetti M, Tiseo G, Giordano C, Nencini E, Russo A, . . . Menichetti F. Time to appropriate antibiotic therapy is a predictor of outcome in patients with bloodstream infection caused by KPC-producing Klebsiella pneumoniae. Crit Care (London Engl). 2020;24(1):29. https://​doi.​org/​10.​1186/​s13054-020-2742-9.CrossRef
14.
go back to reference Meites S, Buffone GJ. Pediatric clinical chemistry, references values, 3rd edn. American Association for Clinical Chemistry. Washington: American Association for Clinical Chemistry; 1989. Meites S, Buffone GJ. Pediatric clinical chemistry, references values, 3rd edn. American Association for Clinical Chemistry. Washington: American Association for Clinical Chemistry; 1989.
20.
go back to reference Clinical and Laboratory Standards Institute. Performance standards for 407 antimicrobial susceptibility testing: 24th informational supplement. CLSI document 408 M100 -S24. Wayne: Clinical and Laboratory Standards Institute; 2014. Clinical and Laboratory Standards Institute. Performance standards for 407 antimicrobial susceptibility testing: 24th informational supplement. CLSI document 408 M100 -S24. Wayne: Clinical and Laboratory Standards Institute; 2014.
Metadata
Title
Time to appropriate antimicrobial therapy serves an independent prognostic indicator in children with nosocomial Klebsiella pneumoniae bloodstream infection
Authors
Jie Cheng
Qinyuan Li
Guangli Zhang
Huiting Xu
Yuanyuan Li
Xiaoyin Tian
Dapeng Chen
Zhengxiu Luo
Publication date
01-12-2022
Publisher
BioMed Central
Published in
BMC Pediatrics / Issue 1/2022
Electronic ISSN: 1471-2431
DOI
https://doi.org/10.1186/s12887-022-03622-6

Other articles of this Issue 1/2022

BMC Pediatrics 1/2022 Go to the issue